[{"id":"finaldose","kind":"company","name":"FinalDose","route":"/companies/finaldose/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/companies.ts","type":"changed","fields":[{"field":"summary","before":"\"Founded by three Oxford PhDs (Jeff Liu, Li-Yao Huang, Steven Lin). The pitch: swap the guide sequence and the same drug becomes a new drug, unlocking 'undruggable' drivers such as MYC, TP53, and APC at the DNA level ...","after":"\"Founded by three Oxford PhDs (Jeff Liu, Li-Yao Huang, Steven Lin). The pitch: swap the guide sequence and the same drug becomes a new drug, unlocking 'undruggable' drivers such as MYC, TP53, and APC at the DNA level ..."}]},{"id":"finaldose","kind":"company","name":"FinalDose","route":"/companies/finaldose/","commit":"335b83f6e7","date":"2026-09-06","author":"Jude Gomila","message":"Expand companies: Katsutake map imports and 44 frontier oncology companies; add frontier technologies (programmable DNA-targeting, fragmento","file":"src/data/companies.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"hq"},{"field":"country"},{"field":"companyType"},{"field":"website"},{"field":"founded"},{"field":"sections"},{"field":"tldr"},{"field":"summary"},{"field":"technologies"},{"field":"targets"},{"field":"tags"},{"field":"links"}]}]